Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice

J Am Soc Nephrol. 1997 May;8(5):720-9. doi: 10.1681/ASN.V85720.

Abstract

Mononuclear cell infiltration in glomeruli and renal interstitium is a prominent feature of some types of glomerulonephritis, including lupus nephritis. The mechanism(s) underlying monocyte influx into the kidney is not fully understood. Recently, monocyte chemoattractant protein-1 (MCP-1) has been identified as a chemotactic factor involved in the recruitment of monocytes/macrophages in the glomeruli of rats with mesangioproliferative as well as anti-glomerular basement membrane glomerulonephritis. In the study presented here, renal MCP-1 mRNA expression in New Zealand Black x New Zealand White (NZB/W) F1 mice, a model of genetically determined immune complex disease that mimics systemic lupus in humans, was investigated. Northern blot analysis revealed a single 0.7 kb MCP-1 transcript of very low intensity in kidneys from 2-month-old NZB/W mice that had not yet developed proteinuria nor renal damage. Message levels, which increased markedly with the progression of nephritis and in association with mononuclear cell infiltration, were 10- and 15- fold higher in 8-10-month-old mice than in 2-month-old mice. By in situ hybridization, increased expression of MCP-1 mRNA was demonstrated in glomeruli and, even more striking, in tubular epithelial cells. Western blot analysis demonstrated increased expression of MCP-1 protein in kidneys of 10-month-old NZB/W mice, consistent with MCP-1 mRNA data. When NZB/W mice were treated with cyclophosphamide up to 12 months of age, expression of MCP-1 in the renal tissue remained low, the influx of inflammatory cells did not appear, and glomerular and tubular structures remained well preserved. These data suggest that elevated MCP-1 might act as a signal for inflammatory cells to infiltrate the kidney in lupus nephritis.

MeSH terms

  • Animals
  • Autoimmune Diseases / metabolism*
  • Autoimmune Diseases / pathology
  • Autoimmune Diseases / physiopathology
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / metabolism*
  • Cyclophosphamide / pharmacology
  • Female
  • Gene Expression
  • Immunosuppressive Agents / pharmacology
  • In Situ Hybridization
  • Kidney / metabolism*
  • Kidney / pathology
  • Kidney / physiopathology
  • Lupus Vulgaris / metabolism*
  • Lupus Vulgaris / pathology
  • Lupus Vulgaris / physiopathology
  • Mice
  • Mice, Inbred NZB
  • Proteinuria / urine
  • Time Factors

Substances

  • Chemokine CCL2
  • Immunosuppressive Agents
  • Cyclophosphamide